+1 888-880-9539Search News by Tag: food and drug administration
434 news stories found
Press Release
April 10, 2010
On January 8, 2010, Parkers Farm, Inc. announced a recall of several of its products due to possible contamination with Listeria monocytogenes.
Read Press Release
Press Release
April 4, 2010
Patients who have had a hernia repaired with a mesh patch should review the latest recall information to see if they are affected, and register for medical monitoring and compensation claims.
Read Press Release
Press Release
February 26, 2010
According to the FDA, the recalled dietary supplements may contain ingredients which are either currently classified as steroids or which it believes should be classified as steroids.
Read Press Release
Press Release
February 10, 2010
Proprietary blend of amino acids helps reduce cravings, inhibit "binge response" in problem drinkers.
Read Press Release
Press Release
February 10, 2010
Thermoflect blankets and other Thermoflect products have been recalled by Encompass Group for relabeling because they may not be safe for use in the Magnetic Resonance (MR) environment, such as during Magnetic Resonance Imaging (MRI).
Read Press Release
Press Release
February 10, 2010
A Class I Recall is the most type of recall issued by the FDA. It means that there is a reasonable probability that the product will cause a serious adverse health event or death if used.
Read Press Release
Press Release
February 1, 2010
Grant Medical Center and the OhioHealth Medical Specialty Foundation opened a practice dedicated to arthritis and other diseases of the joints, muscles and bones.
Read Press Release
Press Release
January 31, 2010
The primary difference between BOTOX and Juvederm is that BOTOX is a muscle relaxer and Juvederm is a tissue filler. Because it is a muscle relaxer, the injectable solution inside a BOTOX injection is a refined solution of botulinum toxin type A.
Read Press Release
Press Release
January 31, 2010
Latisse is a prescription drug used to grow eyelashes that are thicker, fuller and longer. This product is the only one approved by the Food and Drug Administration (FDA) to treat hypotrichosis, a condition characterized by a lack of hair growth.
Read Press Release
Press Release
January 9, 2010
Largely, dental myths imply that dentist enjoy causing pain, or provide unnecessary work to bilk innocent customers out of their hard earned cash. Others still are just based on ignorance of the way our teeth work.
Read Press Release
Press Release
December 18, 2009
An independent laboratory has found that BIOGUARD barrier gauze dressings with Quick-Med's novel NIMBUS antimicrobial technology exhibit high antiviral efficacy against the H1N1 virus.
Read Press Release
Press Release
December 12, 2009
Latisse is the only Food and Drug Administration (FDA) approved treatment for hypotrichosis to grow eyelashes.
Read Press Release
Press Release
December 9, 2009
SigmaPhone.com has released the FDA Drugs app, its flagship and one of the top paid medical apps in iPhone App Store, for Android. Both iPhone/iTouch and Android users can download the app from iTune Store or Android market.
Read Press Release
Press Release
December 8, 2009
Eidogen-Sertanty licensed their Target Informatics Platform (TIP) to the U.S. Food and Drug Administration's National Center for Toxicological Research (NCTR).
Read Press Release
Press Release
December 6, 2009
Patients may contact the Bard Compsix Kugel Mesh Hernia Patch Patient Information Web site and call 1-866-374-0338 to see if they qualify to file a claim for Kugel Mesh Hernia Patch settlement compensation and medical monitoring.
Read Press Release
Press Release
November 20, 2009
Dysport has been called a virtual twin of BOTOX. It is made from the same type of botulinum toxin as BOTOX and it works the same way BOTOX does by paralyzing the muscles.
Read Press Release
Press Release
November 8, 2009
The most popular cosmetic treatment in the United Sates is BOTOX injections to treat wrinkles. In 2007, the latest year for statistics, the American Society of Plastic Surgeons reports that more than 4.5 million BOTOX treatments were given.
Read Press Release
Press Release
October 24, 2009
On May 29, 2009, the Food and Drug Administration and Penumbra Inc. notified healthcare workers that a Class I recall was beginning for the Penumbra Neuron 5F Select Catheter.
Read Press Release
Press Release
October 14, 2009
BOTOX has been in use for over a decade to treat people suffering from conditions related to overactive muscles. Recently, the most common use has become very successfully treating those with facial lines and wrinkles.
Read Press Release